ReNeuron Group PLC (RQE.L)

Pharmaceuticals - Generic & Specialty

Register or Sign in to receive email alerts for items in your favourites whenever we write about them

Share Price

- ( - )
Bid: 1.9p Offer: 2.0p
As of: 22 Nov 2017 00:00
Market Capitalisation: £60.13 million
Shares In Issue: 3,164.62 million
PE: 0
Dividend Yield: 0

Share Performance

52 week high:   3.4p on 30-Nov-16
52 week low:   1.6p on 18-Oct-17

Financial History

to Mar '15to Mar '16to Mar '17
Operating Profit-£10m-£14m-£20m
Total Operating Expense£10m£14m£20m
Net Profit-£9m-£11m-£16m
Net Profit Before Taxes-£10m-£13m-£18m
Net Profit After Taxes-£9m-£11m-£16m

Sponsored by:

Company Information
Number of Shares Out 3,164.62m
Number of Shares Floating 3,047.32m
Number of Common Share Holders
Number of Employees 53
Key Figures
Volume (10 day Avg.) 1.23278m
Turnover £0.05m
Profit Before Tax £-18.13m
EPS -0.49p
Cashflow Per Share -0.49p
Cash Per Share 1.68p